Armata Pharmaceuticals (ARMP) EBT Margin (2013 - 2020)
Armata Pharmaceuticals' (ARMP) quarterly EBT Margin came in at 15193.55% in Q2 2020, down 29.2% quarter-over-quarter from 11760.0% in Q4 2017.
Powered by 
Analysis
Armata Pharmaceuticals (ARMP) EBT Margin (2013 - 2020) Analysis & Trends
Armata Pharmaceuticals has disclosed EBT Margin across 6 years of filings, most recently posting 15193.55% for Q2 2020.
- In Q2 2020, EBT Margin changed N/A year-over-year to 15193.55%; the TTM figure through Jun 2020 stood at 18229.91% (changed N/A YoY), while the FY2017 annual figure was 12295.65%, down 483642.0% from the prior year.
- EBT Margin came in at 15193.55% for Q2 2020 at Armata Pharmaceuticals, down from 11760.0% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 2050.0% in Q3 2017 to a low of 45709.09% in Q4 2016.
- Average EBT Margin over 3 years is 14468.29%, with a median of 11586.21% recorded in 2017.
- Year-over-year, EBT Margin tumbled 4341222 bps in 2016 and jumped 3394909 bps in 2017.
- Over 3 years, EBT Margin stood at 45709.09% in 2016, then surged by 74 bps to 11760.0% in 2017, then retreated by 29 bps to 15193.55% in 2020.
- Per Business Quant data, the three most recent EBT Margin figures were 15193.55% in Q2 2020, 11760.0% in Q4 2017, and 2050.0% in Q3 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 27.53% |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -131.41% |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 41.75% |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 35.61% |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 35.78% |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | -528.97% |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 13.77% |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 4.84% |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | -20,427.46% |
| 10 | Armata Pharmaceuticals | 203.22 Mn | 179.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2020 | -15,193.55% |
| Dec 31, 2017 | -11,760.00% |
| Sep 30, 2017 | -2,050.00% |
| Jun 30, 2017 | -27,725.00% |
| Mar 31, 2017 | -11,586.21% |
| Dec 31, 2016 | -45,709.09% |
| Sep 30, 2016 | -8,189.66% |
| Jun 30, 2016 | -3,738.83% |
| Mar 31, 2016 | -4,262.26% |
| Dec 31, 2015 | -2,296.88% |
| Sep 30, 2015 | -1,607.69% |
| Jun 30, 2015 | -2,541.18% |
| Mar 31, 2015 | -2,645.10% |
| Dec 31, 2014 | 34,279.21% |
| Sep 30, 2014 | -5,078.64% |
| Jun 30, 2014 | -3,710.89% |
| Mar 31, 2014 | -10,872.12% |
| Dec 31, 2013 | 21,647.62% |
| Sep 30, 2013 | -78,333.33% |
| Jun 30, 2013 | -1,991.08% |